(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1349348 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of NOCT mRNA CTD PMID:22079256 1,2-dichloroethane decreases expression ISO RGD:1618439 6480464 ethylene dichloride results in decreased expression of NOCT mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1618439 6480464 1, 2-Dimethylhydrazine results in decreased expression of NOCT mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of NOCT mRNA CTD PMID:25380136 17beta-estradiol decreases expression ISO RGD:1618439 6480464 Estradiol results in decreased expression of NOCT mRNA CTD PMID:19484750 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of NOCT mRNA CTD PMID:35192832 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CCRN4L mRNA CTD PMID:32145629 17beta-estradiol increases expression ISO RGD:1618439 6480464 Estradiol results in increased expression of NOCT mRNA CTD PMID:25210133 17beta-estradiol increases expression ISO RGD:1349348 6480464 Estradiol results in increased expression of NOCT mRNA CTD PMID:23019147 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1618439 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',5,5'-tetrachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:23829299 2,3',4,4',5-Pentachlorobiphenyl affects expression ISO RGD:1618439 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NOCT mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of NOCT mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of NOCT mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1618439 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28213091 , PMID:28433925 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1618439 6480464 Tetrachlorodibenzodioxin results in increased expression of NOCT mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1618439 6480464 Tetrachlorodibenzodioxin affects the expression of NOCT mRNA CTD PMID:21570461 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1618439 6480464 Tetrachlorodibenzodioxin results in decreased expression of NOCT mRNA CTD PMID:19770486 , PMID:19933214 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-hydroxypropanoic acid increases expression ISO RGD:1349348 6480464 Lactic Acid results in increased expression of NOCT mRNA CTD PMID:30851411 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1618439 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of NOCT mRNA CTD PMID:24848799 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of NOCT mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol decreases expression ISO RGD:1618439 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of NOCT mRNA CTD PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO RGD:1618439 6480464 Fenretinide results in increased expression of NOCT mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CCRN4L mRNA CTD PMID:30047161 acrylamide increases expression ISO RGD:1349348 6480464 Acrylamide results in increased expression of NOCT mRNA CTD PMID:32763439 Actein decreases expression EXP 6480464 actein results in decreased expression of NOCT protein CTD PMID:29969672 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of NOCT mRNA CTD PMID:33354967 all-trans-retinoic acid decreases expression ISO RGD:1618439 6480464 Tretinoin results in decreased expression of NOCT mRNA CTD PMID:16604517 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NOCT mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of NOCT mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO RGD:1349348 6480464 Antirheumatic Agents results in decreased expression of NOCT mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:1349348 6480464 aristolochic acid I results in increased expression of NOCT mRNA CTD PMID:33212167 avobenzone increases expression ISO RGD:1349348 6480464 avobenzone results in increased expression of NOCT mRNA CTD PMID:31016361 belinostat multiple interactions ISO RGD:1349348 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOCT mRNA CTD PMID:27188386 benzo[a]pyrene decreases expression ISO RGD:1618439 6480464 Benzo(a)pyrene results in decreased expression of NOCT mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:1349348 6480464 Benzo(a)pyrene results in increased expression of NOCT mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:1618439 6480464 Benzo(a)pyrene results in increased methylation of NOCT exon, Benzo(a)pyrene results in increased methylation of NOCT intron CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1618439 6480464 Benzo(a)pyrene results in increased expression of NOCT mRNA CTD PMID:22228805 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NOCT mRNA CTD PMID:18164116 bilirubin IXalpha increases expression ISO RGD:1349348 6480464 Bilirubin results in increased expression of NOCT mRNA CTD PMID:20196124 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1618439 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1349348 6480464 Diethylhexyl Phthalate results in increased expression of NOCT mRNA CTD PMID:31163220 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NOCT mRNA CTD PMID:25181051 more ... bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CCRN4L mRNA CTD PMID:32145629 bisphenol A decreases expression ISO RGD:1349348 6480464 bisphenol A results in decreased expression of NOCT mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:1618439 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A affects methylation ISO RGD:1618439 6480464 bisphenol A affects the methylation of NOCT promoter CTD PMID:27334623 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of NOCT mRNA CTD PMID:32479839 cannabidiol decreases expression ISO RGD:1618439 6480464 Cannabidiol results in decreased expression of NOCT mRNA CTD PMID:30307084 carbon nanotube affects expression ISO RGD:1618439 6480464 Nanotubes, Carbon analog affects the expression of NOCT mRNA CTD PMID:25620056 carbon nanotube decreases expression ISO RGD:1618439 6480464 Nanotubes, Carbon results in decreased expression of NOCT mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:1618439 6480464 Nanotubes more ... CTD PMID:25554681 choline multiple interactions ISO RGD:1618439 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NOCT mRNA CTD PMID:20938992 cisplatin increases expression ISO RGD:1349348 6480464 Cisplatin results in increased expression of NOCT mRNA CTD PMID:19561079 cisplatin multiple interactions ISO RGD:1349348 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of NOCT mRNA CTD PMID:27392435 clofibrate multiple interactions ISO RGD:1618439 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of NOCT mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NOCT mRNA] CTD PMID:17585979 copper(II) sulfate increases expression ISO RGD:1349348 6480464 Copper Sulfate results in increased expression of NOCT mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1349348 6480464 Asbestos, Crocidolite results in increased expression of NOCT mRNA CTD PMID:18687144 crocidolite asbestos affects expression ISO RGD:1349348 6480464 Asbestos, Crocidolite affects the expression of NOCT mRNA CTD PMID:25757056 cyclosporin A increases expression ISO RGD:1349348 6480464 Cyclosporine results in increased expression of NOCT mRNA CTD PMID:25562108 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of NOCT mRNA CTD PMID:23640034 dexamethasone multiple interactions ISO RGD:1618439 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of NOCT mRNA CTD PMID:24848799 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of NOCT mRNA CTD PMID:21266533 dicrotophos increases expression ISO RGD:1349348 6480464 dicrotophos results in increased expression of NOCT mRNA CTD PMID:28302478 dimethylarsinic acid multiple interactions ISO RGD:1618439 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NOCT mRNA CTD PMID:34876320 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NOCT mRNA CTD PMID:33729688 diquat increases expression ISO RGD:1618439 6480464 Diquat results in increased expression of NOCT mRNA CTD PMID:36851058 dorsomorphin multiple interactions ISO RGD:1349348 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1349348 6480464 Doxorubicin results in decreased expression of NOCT mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of NOCT mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1349348 6480464 entinostat results in increased expression of NOCT mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1349348 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOCT mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO RGD:1618439 6480464 epoxiconazole results in decreased expression of NOCT mRNA CTD PMID:35436446 erythromycin estolate decreases expression EXP 6480464 Erythromycin Estolate results in decreased expression of NOCT mRNA CTD PMID:24412560 ethanol increases expression ISO RGD:1618439 6480464 Ethanol results in increased expression of NOCT mRNA CTD PMID:19167417 ethanol affects splicing ISO RGD:1618439 6480464 Ethanol affects the splicing of NOCT mRNA CTD PMID:30319688 folic acid multiple interactions ISO RGD:1618439 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NOCT mRNA CTD PMID:20938992 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of NOCT mRNA CTD PMID:33387578 graphene oxide increases expression ISO RGD:1618439 6480464 graphene oxide results in increased expression of NOCT mRNA CTD PMID:33227293 graphite affects expression EXP 6480464 Graphite affects the expression of NOCT mRNA CTD PMID:29933104 indinavir multiple interactions ISO RGD:1618439 6480464 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of NOCT mRNA CTD PMID:16931933 isoprenaline increases expression ISO RGD:1618439 6480464 Isoproterenol results in increased expression of NOCT mRNA CTD PMID:20003209 L-methionine multiple interactions ISO RGD:1618439 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NOCT mRNA CTD PMID:20938992 lamivudine multiple interactions ISO RGD:1618439 6480464 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of NOCT mRNA more ... CTD PMID:16931933 Licochalcone B increases expression ISO RGD:1349348 6480464 licochalcone B results in increased expression of NOCT mRNA CTD PMID:33647349 lipopolysaccharide multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of NOCT mRNA CTD PMID:16415329 lipopolysaccharide multiple interactions ISO RGD:1349348 6480464 [S-(1 more ... CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:1349348 6480464 Lipopolysaccharides results in increased expression of NOCT mRNA CTD PMID:35811015 mercury dibromide multiple interactions ISO RGD:1349348 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOCT mRNA CTD PMID:27188386 mercury dibromide increases expression ISO RGD:1349348 6480464 mercuric bromide results in increased expression of NOCT mRNA CTD PMID:26272509 metformin affects expression EXP 6480464 Metformin affects the expression of NOCT mRNA CTD PMID:31324951 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of NOCT mRNA CTD PMID:19564919 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of NOCT mRNA CTD PMID:30467583 methimazole increases expression EXP 6480464 Methimazole results in increased expression of CCRN4L mRNA CTD PMID:30047161 methotrexate affects expression ISO RGD:1618439 6480464 Methotrexate affects the expression of NOCT mRNA CTD PMID:18502557 methylarsonic acid multiple interactions ISO RGD:1618439 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NOCT mRNA CTD PMID:34876320 methylisothiazolinone increases expression ISO RGD:1349348 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of NOCT mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1349348 6480464 methylmercuric chloride results in increased expression of NOCT mRNA CTD PMID:28001369 milrinone increases expression EXP 6480464 Milrinone results in increased expression of NOCT mRNA CTD PMID:22936366 N-methylformamide decreases expression ISO RGD:1618439 6480464 methylformamide analog results in decreased expression of NOCT mRNA, methylformamide results in decreased expression of NOCT mRNA CTD PMID:17040096 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of NOCT mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NOCT mRNA CTD PMID:18164116 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of NOCT mRNA CTD PMID:25380136 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of NOCT mRNA CTD PMID:16415329 nickel atom increases expression ISO RGD:1349348 6480464 Nickel results in increased expression of NOCT mRNA CTD PMID:23195993 , PMID:25583101 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of NOCT mRNA CTD PMID:23665939 panobinostat increases expression ISO RGD:1349348 6480464 panobinostat results in increased expression of NOCT mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1349348 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOCT mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:1618439 6480464 Acetaminophen affects the expression of NOCT mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of NOCT mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1349348 6480464 Acetaminophen results in increased expression of NOCT mRNA CTD PMID:21420995 , PMID:29067470 paracetamol multiple interactions ISO RGD:1618439 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of NOCT mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NOCT mRNA] CTD PMID:17585979 paraquat increases expression EXP 6480464 Paraquat results in increased expression of NOCT mRNA CTD PMID:32680482 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of NOCT mRNA CTD PMID:31324951 phenobarbital increases expression ISO RGD:1618439 6480464 Phenobarbital results in increased expression of NOCT mRNA CTD PMID:19270015 phenobarbital decreases expression ISO RGD:1618439 6480464 Phenobarbital results in decreased expression of NOCT mRNA CTD PMID:19270015 phenobarbital affects expression ISO RGD:1618439 6480464 Phenobarbital affects the expression of NOCT mRNA CTD PMID:23091169 phenylmercury acetate multiple interactions ISO RGD:1349348 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOCT mRNA CTD PMID:27188386 phenylmercury acetate increases expression ISO RGD:1349348 6480464 Phenylmercuric Acetate results in increased expression of NOCT mRNA CTD PMID:26272509 pirinixic acid decreases expression ISO RGD:1618439 6480464 pirinixic acid results in decreased expression of NOCT mRNA CTD PMID:23811191 pirinixic acid increases expression ISO RGD:1618439 6480464 pirinixic acid results in increased expression of NOCT mRNA CTD PMID:18301758 , PMID:18445702 potassium chromate multiple interactions ISO RGD:1349348 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of NOCT mRNA CTD PMID:22079256 potassium chromate increases expression ISO RGD:1349348 6480464 potassium chromate(VI) results in increased expression of NOCT mRNA CTD PMID:22079256 propiconazole increases expression ISO RGD:1618439 6480464 propiconazole results in increased expression of NOCT mRNA CTD PMID:21278054 rac-lactic acid increases expression ISO RGD:1349348 6480464 Lactic Acid results in increased expression of NOCT mRNA CTD PMID:30851411 ranitidine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of NOCT mRNA CTD PMID:16415329 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1349348 6480464 [S-(1 more ... CTD PMID:35811015 saquinavir multiple interactions ISO RGD:1618439 6480464 [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of NOCT mRNA CTD PMID:16931933 SB 431542 multiple interactions ISO RGD:1349348 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of NOCT mRNA CTD PMID:15967596 sodium arsenate multiple interactions ISO RGD:1618439 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NOCT mRNA CTD PMID:34876320 sodium arsenite multiple interactions ISO RGD:1618439 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of NOCT mRNA CTD PMID:34876320 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of NOCT mRNA CTD PMID:22561333 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of CCRN4L mRNA CTD PMID:30047161 tamoxifen affects expression ISO RGD:1618439 6480464 Tamoxifen affects the expression of NOCT mRNA CTD PMID:20937368 temozolomide increases expression ISO RGD:1349348 6480464 Temozolomide results in increased expression of NOCT mRNA CTD PMID:31758290 tetrachloromethane affects expression ISO RGD:1618439 6480464 Carbon Tetrachloride affects the expression of NOCT mRNA CTD PMID:31919559 titanium dioxide increases expression ISO RGD:1349348 6480464 titanium dioxide results in increased expression of NOCT mRNA CTD PMID:34973136 tributylstannane increases expression ISO RGD:1618439 6480464 tributyltin results in increased expression of NOCT mRNA CTD PMID:24848799 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of NOCT mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1349348 6480464 trichostatin A results in increased expression of NOCT mRNA CTD PMID:24935251 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of NOCT mRNA CTD PMID:30589522 triptonide increases expression ISO RGD:1618439 6480464 triptonide results in increased expression of NOCT mRNA CTD PMID:33045310 trovafloxacin multiple interactions ISO RGD:1618439 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NOCT mRNA CTD PMID:18930950 urethane increases expression ISO RGD:1349348 6480464 Urethane results in increased expression of NOCT mRNA CTD PMID:28818685 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of NOCT mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:1349348 6480464 Valproic Acid affects the expression of NOCT mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1349348 6480464 Valproic Acid results in increased expression of NOCT mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1349348 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOCT mRNA CTD PMID:27188386 valproic acid affects expression ISO RGD:1618439 6480464 Valproic Acid affects the expression of NOCT mRNA CTD PMID:17292431 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of NOCT mRNA CTD PMID:23034163 zidovudine multiple interactions ISO RGD:1618439 6480464 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of NOCT mRNA more ... CTD PMID:16931933
